Prospective open-label randomized parallel groups study to compare efficacy and safety of Indinol Forto® 200 mg capsules and Visanne 2 mg tablets in treatment of endometriosis. This is phase 3 study, based on hypothesis of non-inferiority.
Protocol Amendment History
1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-02.